ACTD vs CTD Format: Comprehensive Guide to Global and Regional Dossier Strategies ACTD vs CTD Explained: Compliance-Ready Guide for Dossier Preparation Introduction to ACTD and CTD Formats The Common Technical Document (CTD) and the ASEAN Common Technical Dossier (ACTD) are two of the most widely recognized formats for regulatory submissions worldwide. The CTD, developed by the International Council for Harmonisation (ICH), has become the global gold standard, mandated by major agencies including the FDA, EMA, PMDA, and Health Canada. In contrast, the ACTD is specific to the ASEAN region, harmonizing dossier submissions across ten Southeast Asian member states. Understanding the…

ACTD vs CTD: Executive Side-by-Side Mapping of Modules 1–5 for Fast Global Submissions ACTD vs CTD, Explained: What Changes by Module—and How to Convert Without Rewriting Your Science Why ACTD vs CTD Matters Now: Regions, Business Drivers, and How to Think About “Same Science, Different Wrappers” The ASEAN Common Technical Dossier (ACTD) and the ICH Common Technical Document (CTD) aim to standardize how sponsors present evidence—but they differ in administrative wrappers, section ordering nuances, and regional expectations. If you develop in the USA/EU first, you will likely author in CTD (and file as eCTD where required). When you expand to…

From FDA CTD to ACTD: A Step-by-Step Conversion Guide for US Sponsors US CTD to ACTD, Without Rewriting Your Science: A Practical Conversion Playbook Start With the Scientific Core: Freeze the CTD, Then Design ACTD “Wrappers” Around It Conversion goes fast when you begin with a frozen, reference CTD—not a moving draft. Lock your US core first: Module 2 summaries (QOS, nonclinical and clinical overviews), a verifiable Module 3 control strategy (attribute-level spec rationale tied to clinical relevance, capability, and method performance), GLP/QAU-backed Module 4 with explicit exposure margins, and Module 5 CSRs conformant to ICH E3 with stable table/figure…

ACTD Module 1 (Administrative) for ASEAN: Country Forms, Legalizations, and Signature Control Mastering ACTD Module 1: Country Forms, Legalizations, and Signature Workflows What ACTD Module 1 Includes—and Why It Drives Your ASEAN Timelines ACTD Module 1 is the administrative wrapper that national authorities use to verify identity, authority, and eligibility of the product and the Marketing Authorization Holder (MAH). For US/EU teams accustomed to CTD/eCTD, it helps to think of Module 1 as the dossier passport: application forms, cover letters, Power of Attorney (POA) or authorization letters, manufacturer/importer/distributor licenses, GMP certificates, Certificates of Pharmaceutical Product (CoPP) or Free Sale Certificates…

  Mapping CMC for ACTD: Placing Specs, Validation, and Stability When You Start from CTD Why CMC Mapping Matters: “Same Science, Different Wrapper” and the Risk of Silent Drift Quality/CMC is the backbone of any dossier, and it travels surprisingly well across formats—if you place it correctly. The ICH CTD organizes quality in Module 3 as 3.2.S (Drug Substance) and 3.2.P (Drug Product) with familiar sub-sections for pharmaceutical development, manufacturing, controls, validation, packaging, and stability. The ACTD quality section carries the same scientific intent but can present different headings and granularity expectations, especially for administrative attachments and country add-ons. Teams…

Clinical & Nonclinical in ACTD: Placement, Reviewer-Ready Summaries, and How to Avoid the Common Gaps Placing Clinical & Nonclinical Content in ACTD: What Goes Where and How to Keep It Reviewer-Ready What Moves Where: ACTD Placement Versus CTD for Modules 4–5 and the Role of Module 2 Summaries When US/EU teams port a CTD core into an ACTD package, most of the clinical (Module 5) and nonclinical (Module 4) science can travel 1:1. The differences are about placement headings, granularity, and navigation—not about re-analyzing data. In the CTD world, ICH M4 defines a stable skeleton with Module 4 study reports…

Labeling in ACTD Markets: Leaflets, Artwork, and Language Localization vs SPL ACTD Labeling Done Right: From US PI/SPL to Local Leaflets, Artwork, and Language-Perfect Files From US PI/SPL to ACTD Leaflets: What Actually Changes—and What Must Never Change In the United States, labeling lives as a PLR-formatted Prescribing Information (PI) plus machine-readable SPL XML. In many ACTD markets, labeling is delivered as PDF leaflets for healthcare professionals and patients, alongside carton/container artwork placed in Module 1. The format changes; the story must not. Your objective is to translate the same evidence-anchored claims, warnings, and instructions from the CTD core into…

ACTD eSubmission: File Naming, Granularity Choices, and Portal Nuances That Keep Dossiers Moving ACTD eSubmission Without Rework: Smart Naming, Right Granularity, and Smooth Portal Packaging ACTD eSubmission Is Not “Just Upload the PDFs”: Think Reviewer Experience, Not File Dumps Many US/EU teams arrive at ACTD markets assuming “it’s just a set of PDFs.” That mindset misses how regulators actually read. Whether the authority uses a full XML backbone or a simpler portal, reviewers still expect to verify a claim in one or two clicks, land on a caption-level table or figure, and see consistent titles across sequences. In ICH CTD/eCTD…

Post-Approval Changes in ACTD vs US: Variations, CBE-30/CBE-0/PAS Mapping, and Evidence That Passes First Time ACTD Variations vs US Supplements: How to Classify, Evidence, and Ship Post-Approval Changes Fast Why Post-Approval Changes Matter in ACTD vs US: Same Risk Logic, Different Labels Once your product is on the market, change is inevitable—new suppliers, alternative sites, tighter specs, equipment upgrades, labeling refinements, or stability-led shelf-life extensions. Regulators everywhere judge these changes through a risk lens: Does the change alter quality, safety, or efficacy? If yes, how much and what evidence proves control? In the United States, this logic is captured in…

Stability in ACTD: Climatic Zones, Repackaging Evidence, and Country Add-Ons (US-First Conversion Guide) ACTD Stability Requirements Made Practical: Zone IV Design, Repackaging Proof, and Country-Specific Add-Ons Why Stability Drives ACTD Timelines: Zone IV Reality, Pack Coverage, and the “Label Parity” Test For US-first teams moving a CTD dossier into ACTD markets, stability is where schedules are won or lost. ASEAN authorities expect evidence that the same product performs under hot and humid climatic conditions—often more demanding than the studies used to support a US/EU launch. A sponsor who tries to “port” 25 °C/60% RH long-term data without a plan for zone…